Trial Over Children’s Cough Syrup Deaths Resumes In The Gambia

Attendees arrive at the High Court in Banjul on October 24, 2023. A trial opened on October 24, 2023 in The Gambia's capital Banjul over the deaths last year of small children who took a cough syrup made by the India-based Maiden Pharmaceuticals. Some 70 children aged 5 and under died in 2022 after taking the over-the-counter medicines, leading to a national outcry in the West African nation of about 2.5 million people. Justice Ebrima Jaiteh of the High Court in Banjul adjourned the proceedings until November 7 after finding that three state defendants who had failed to appear "lacked diligence". (Photo by Muhamadou BITTAYE / AFP)

The trial in the adulterated syrups affair which caused the death of children last year in The Gambia resumed Tuesday, before the Banjul High Court.

The families of the victims, grouped within the AKI association, are awaiting convictions at the end of this trial which was delayed in July and then postned in October after the five defendants did not attend the hearing.

It was gathered that some 70 children aged 5 bellow., lost their lives in 2022 from kidney failure after taking the over-the-counter medicines.

Nineteen plaintiffs are suing five defendants, company Maiden Pharmaceuticals, local distributor Atlantic Pharmaceuticals, the Medical Controls Agency, the Ministry of Health and Attorney General Dawda A. Jallow, demand they admit that the children were killed by consuming contaminated medicines.

Meanwhile, in July, a government taskforce in The Gambia announced its finding that four cough syrups imported from India were responsible for the deaths.

Plaintiffs are demanding about $230,000 per child in damages.

They are also suing for an admission that the MCA failed in its statutory duty to regulate the quality and safety of medicines.

The Gambian government also said it was exploring options to take legal action against the Indian manufacturer.

According to the World Health Organization (WHO), lab tests found “unacceptable amounts” of diethylene glycol and ethylene glycol, which are commonly used as antifreeze and can be fatal when ingested.

Beginning in September last year, The Gambia ordered a recall of several cough and cold medications, as well as all products manufactured by the Indian laboratory Maiden Pharmaceuticals from which the adulterated syrups originated.

In the aftermath of the scandal, India launched an investigation and shut down the Maiden Pharmaceuticals plant last October.

And The Gambia’s president Barrow vowed to create a national laboratory to test for drug quality and food safety, which doens’t exist in the country.